{  "clinical_trials": [    {      "id": "2010-020424-21",      "title": "Betablocker Therapy in Pulmonary Arterial Hypertension",      "phase": "Phase 4",      "registry": "EU-CTR",      "linkout": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2010-020424-21",      "abstract": "Idiopathic pulmonal arterial hypertension MedDRA Classification",      "date": "2010-10-01"    },    {      "id": "2012-001066-14",      "title": "Sympathetic renal denervation versus increment of pharmacological treatment in resistant arterial hypertension",      "phase": "Phase 4",      "registry": "EU-CTR",      "linkout": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2012-001066-14",      "abstract": "subjects with resistant hypertension",      "date": "2012-07-17"    },    {      "id": "2009-011156-21",      "title": "Effects of beta-blockers on exercise performance in uncomplicated hypertension",      "phase": "Phase 3",      "registry": "EU-CTR",      "linkout": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2009-011156-21",      "abstract": "Non complicated arterial hypertension",      "date": "2011-04-28"    },    {      "id": "2008-000804-10",      "title": "Valsartan 160 mg and hydrochlorothiazide 25 mg in subject suffering from arterial hypertension stage 1 or high normal with organ damage",      "phase": "Phase 4",      "registry": "EU-CTR",      "linkout": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2008-000804-10",      "abstract": "Arterial Hypertension with organ damage MedDRA Classification",      "date": "2008-03-31"    },    {      "id": "2008-005885-30",      "title": "A PHASE 3 MULTI-CENTER RANDOMIZED DOUBLE-BLIND PLACEBOCONTROLLED SAFETY AND EFFICACY STUDY OF SITAXSENTAN SODIUM IN SUBJECTS WITH PULMONARY ARTERIAL HYPERTENSION",      "phase": "Phase 3",      "registry": "EU-CTR",      "linkout": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2008-005885-30",      "HRCS_HC": [        {          "id": "894",          "name": "Cardiovascular"        }      ],      "abstract": "Pulmonary arterial hypertension MedDRA Classification",      "date": "2009-06-06"    },    {      "id": "2004-003847-37",      "title": "An Open label uncontrolled study of the safety and efficacy of chronic intravenous Remodulin in patients with pulmonary Arterial Hypertension",      "phase": "Phase 3",      "registry": "EU-CTR",      "linkout": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2004-003847-37",      "abstract": "Pulmonary Arterial Hypertension MedDRA Classification",      "date": "2004-12-21"    },    {      "id": "2004-004863-32",      "title": "EFFECTS OF NEBIVOLOL ON THE WALKING ABILITY IN PATIENTS WITH ESSENTIAL HYPERTENSION AND PERIPHERAL ARTERIAL DISEASE INTERMITTENT CLAUDICATION",      "phase": "Phase 4",      "registry": "EU-CTR",      "linkout": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2004-004863-32",      "HRCS_HC": [        {          "id": "894",          "name": "Cardiovascular"        }      ],      "abstract": "ESSENTIAL HYPERTENSION AND PERIPHERAL ARTERIAL DISEASE INTERMITTENT CLAUDICATION  MedDRA Classification",      "date": "2006-05-19"    },    {      "id": "2005-000812-29",      "title": "ARIES-1  Ambrisentan in PAH  A Phase III Randomized Double-Blind Placebo-Controlled Multicenter Efficacy Study of Ambrisentan in Subjects with Pulmonary Arterial Hypertension",      "phase": "Phase 3",      "registry": "EU-CTR",      "linkout": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2005-000812-29",      "HRCS_HC": [        {          "id": "894",          "name": "Cardiovascular"        }      ],      "abstract": "Pulmonary Arterial Hypertension MedDRA Classification",      "date": "2005-11-08"    },    {      "id": "2005-001193-28",      "title": "ARIES-320321-E  A Long-Term Study of Ambrisentan in Pulmonary Arterial Hypertension Subjects Having Completed AMB-320 or AMB-321",      "phase": "Phase 3",      "registry": "EU-CTR",      "linkout": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2005-001193-28",      "abstract": "Pulmonary Arterial Hypertension MedDRA Classification",      "date": "2005-11-08"    },    {      "title": "Long-term single-arm open-label study to assess the safety and tolerability of ACT-293987 in patients with pulmonary arterial hypertension",      "phase": "Phase 3",      "linkout": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2009-014992-31",      "registry": "EU-CTR",      "id": "2009-014992-31",      "HRCS_HC": [        {          "id": "894",          "name": "Cardiovascular"        }      ],      "abstract": "The intended indication is Pulmonary Arterial Hypertension MedDRA Classification",      "date": "2010-01-19"    },    {      "id": "2007-003694-27",      "title": "SERAPHIN-OL: Study with an ERA in Pulmonary arterial Hypertension to Improve cliNical outcome Open Label Long-term single-arm open-label extension study of the SERAPHIN study to assess the safety and tolerability of macitentanACT 064992 in patients with symptomatic pulmonary arterial hypertension",      "phase": "Phase 3",      "registry": "EU-CTR",      "linkout": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2007-003694-27",      "FOR": [        {          "id": "3048",          "name": "1102 Cardiorespiratory Medicine and Haematology"        }      ],      "HRCS_HC": [        {          "id": "894",          "name": "Cardiovascular"        }      ],      "HRCS_RAC": [        {          "id": "10601",          "name": "6.1 Pharmaceuticals"        }      ],      "RCDC": [        {          "id": "507",          "name": "Clinical Research"        },        {          "id": "367",          "name": "Hypertension"        },        {          "id": "559",          "name": "Rare Diseases"        },        {          "id": "331",          "name": "Cardiovascular"        },        {          "id": "410",          "name": "Lung"        }      ],      "abstract": "symptomatic pulmonary arterial hypertension",      "date": "2011-10-26"    },    {      "id": "2009-014490-41",      "title": "A multicenter double-blind placebo-controlled Phase 3 study assessing the safety and efficacy of selexipag on morbidity and mortality in patients with pulmonary arterial hypertension",      "phase": "Phase 3",      "registry": "EU-CTR",      "linkout": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2009-014490-41",      "HRCS_HC": [        {          "id": "894",          "name": "Cardiovascular"        }      ],      "abstract": "The intended indication is Pulmonary Arterial Hypertension",      "date": "2010-07-28"    },    {      "id": "2010-018322-40",      "title": "A Multicenter Single-arm Open-label Phase 3b Study to Assess the Effects of Switching From Flolan to ACT-385781A in Patients with Pulmonary Arterial Hypertension",      "phase": "Phase 3",      "registry": "EU-CTR",      "linkout": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2010-018322-40",      "abstract": "Pulmonary Arterial Hypertension",      "date": "2010-04-27"    },    {      "id": "2011-002943-92",      "title": "A Single-arm Open Label Study Evaluating the Impact on Lifestyle of a New Thermo Stable Formulation of FLOLAN in Subjects with Pulmonary Arterial Hypertension PAH",      "phase": "Phase 4",      "registry": "EU-CTR",      "linkout": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2011-002943-92",      "abstract": "pulmonary arterial hypertension PAH",      "date": "2011-08-19"    },    {      "id": "2012-002354-23",      "title": "A Double-Blind Efficacy and Safety Study of the Phosphodiesterase Type 5 Inhibitor Tadalafil in Pediatric Patients with Pulmonary Arterial Hypertension",      "phase": "Phase 3",      "registry": "EU-CTR",      "linkout": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2012-002354-23",      "abstract": "Pulmonary Arterial Hypertension",      "date": "2013-04-12"    },    {      "id": "2014-004167-20",      "title": "A Phase 3 Multi-Center Open-Label Study To Confirm Safety Efficacy And Tolerability Of Sildenafil Citrate 20 Mg Three Times a Day TID In Subjects With Pulmonary Arterial Hypertension",      "phase": "Phase 3",      "registry": "EU-CTR",      "linkout": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2014-004167-20",      "HRCS_HC": [        {          "id": "894",          "name": "Cardiovascular"        }      ],      "abstract": "Pulmonary Arterial Hypertension",      "date": "2015-03-24"    },    {      "id": "2016-000196-24",      "title": "A STUDY OF THE EFFICACY AND SAFETY OF BARDOXOLONE METHYL IN PATIENTS WITH CONNECTIVE TISSUE DISEASE-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION",      "phase": "Phase 3",      "registry": "EU-CTR",      "linkout": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2016-000196-24",      "HRCS_HC": [        {          "id": "894",          "name": "Cardiovascular"        }      ],      "abstract": "Connective Tissue Disease-Associated Pulmonary Arterial Hypertension WHO Group I CTD-PAH",      "date": "2016-08-18"    },    {      "id": "2006-002235-25",      "title": "A Randomized Double-Blind Placebo Controlled Dose Ranging Parallel Group Study of Oral Sildenafil in the Treatment of Children Aged 1-17 Years With Pulmonary Arterial Hypertension",      "phase": "Phase 3",      "registry": "EU-CTR",      "linkout": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2006-002235-25",      "HRCS_HC": [        {          "id": "894",          "name": "Cardiovascular"        }      ],      "abstract": "Pulmonary Arterial Hypertension",      "date": "2012-03-07"    },    {      "id": "2016-003978-41",      "title": "A Phase 3 Multi-center Open label Study To Investigate Safety Efficacy And Tolerability Of Sildenafil Citrate In Pediatric Patients With Pulmonary Arterial Hypertension",      "phase": "Phase 3",      "registry": "EU-CTR",      "linkout": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2016-003978-41",      "HRCS_HC": [        {          "id": "894",          "name": "Cardiovascular"        }      ],      "abstract": "Pulmonary arterial hypertension",      "date": "2016-10-13"    },    {      "id": "2017-000216-42",      "registry": "EU-CTR",      "linkout": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=2017-000216-42",      "title": "A multi-center double-blind placebo-controlled Phase 4 study in patients with pulmonary arterial hypertension to assess the effect of selexipag on daily life physical activity and patients self-reported symptoms and their impacts",      "phase": "Phase 4",      "HRCS_HC": [        {          "id": "894",          "name": "Cardiovascular"        },        {          "id": "896",          "name": "Respiratory"        }      ],      "abstract": "Pulmonary arterial hypertension",      "date": "2017-07-21"    }  ]}